ml 7 has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, F | 1 |
| Liu, M | 1 |
| Tieniber, A | 1 |
| Etherington, MS | 1 |
| Hanna, A | 1 |
| Vitiello, GA | 1 |
| Param, NJ | 1 |
| Do, K | 1 |
| Wang, L | 1 |
| Antonescu, CR | 1 |
| Zeng, S | 1 |
| Zhang, JQ | 1 |
| DeMatteo, RP | 1 |
1 other study available for ml 7 and Gastrointestinal Stromal Neoplasm
| Article | Year |
|---|---|
Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V-Mutant Gastrointestinal Stromal Tumor.
Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Myosins | 2023 |